Synlogic
About:
Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.
Website: http://synlogictx.com
Twitter/X: synlogic_tx
Top Investors: OrbiMed, Deerfield, Perceptive Advisors, Ginkgo Bioworks, New Enterprise Associates
Description:
Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases. The company's lead programs target patients with rare genetic metabolic diseases, including phenylketonuria and secondary hyperoxaluria. Synlogic is also hard at work on synthetic biotics to address more prevalent conditions, including inflammatory bowel disease, cancer, and other metabolic conditions.
$472M
$1M to $10M
Cambridge, Massachusetts, United States
2014-01-01
info(AT)synlogictx.com
Alison Silva, Ankit Mahadevia, Dean Falb, Jim Collins, Timothy K. Lu
51-100
2023-09-29
Public
© 2025 bioDAO.ai